Taro Pharmaceutical Industries (TARO)
Add to Watchlists Create an Alert
63.82
-0.16 -0.25%
NYSE
May 22, 8:00PM
BATS Real time
Currency in USD
Taro Pharmaceutical Industries Free Cash Flow:
87.90M for Dec. 31, 2012Taro Pharmaceutical Industries Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 87.90M |
| Sept. 30, 2012 | 60.84M |
| June 30, 2012 | 17.40M |
| March 31, 2012 | |
| Dec. 31, 2011 | 58.92M |
| Sept. 30, 2011 | 60.73M |
| June 30, 2011 | 32.00M |
| March 31, 2011 | 23.47M |
| Dec. 31, 2010 | 29.44M |
| Sept. 30, 2010 | 9.575M |
| June 30, 2010 | 5.65M |
| March 31, 2010 | 15.07M |
| Dec. 31, 2009 | |
| Sept. 30, 2009 | 43.07M |
| June 30, 2009 | 11.79M |
| March 31, 2009 | |
| Dec. 31, 2008 | |
| Sept. 30, 2008 | 37.68M |
| June 30, 2008 | 21.28M |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
TARO Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Perrigo Company | 126.31M |
| Valeant Pharmaceuticals International | 240.60M |
| Pernix Therapeutics | 4.754M |
TARO Free Cash Flow Rankings
| Overall |
93rd percentile 543 of 8006 |
| Sector |
91st percentile 55 of 686 in Healthcare |
| Industry |
89th percentile 7 of 68 in Drug Manufacturers - Specialty & Generic |
TARO Free Cash Flow Range, Past 5 Years
| Minimum | 5.650M | Jun 2010 |
| Maximum | 87.90M | Dec 2012 |
| Average | 34.32M |
